Please contact us for more information or to learn if you are eligible to participate.
To determine the effect of once-daily, oral administration of 80 or 100 mg MGL-3196 versus matching placebo on NASH
Fernando Membreno, MD
Madrigal Pharmaceuticals, Inc.
Type of Trial